Capital Women’s Care will provide leva to patients at 55 locations in Maryland, Virginia and Washington DC


Mid-Atlantic’s Largest Private OB/GYN Practice Recommends Leva to Patients

BOSTON, March 7, 2022 /PRNewswire/ — Renovia Inc. (“Renovia”), a women-led company developing digital therapies for female pelvic floor disorders, today announced that Capital Women’s Care recommends the raised® Pelvic Health System to its patients who are experiencing

mild to moderate stress, mixed and urge urinary incontinence (including overactive bladder). Capital Women’s Care is Mid-Atlantic’s largest private OB/GYN practice with over 200 providers in more than 55 locations across Maryland, Virginiaand washington d.c..

The latest data shows that 62% of adult women in the United States suffer from urinary incontinence, which can negatively impact quality of life and contribute to other important and potentially serious medical conditions. Many studies show that pelvic floor muscle training (PFMT), commonly known as “Kegels”, can help reduce symptoms of UI by strengthening a woman’s pelvic floor muscles. However, only 25% of women who perform Kegel exercises do so effectively, limiting the potential positive impact on UI symptoms. the raised Pelvic Health System is a Food and Drug Administration (FDA) approved combination device and app for the treatment of mild to moderate stress, mixed, and urgency urinary incontinence (including overactive bladder). It combines the raised sensor with a smartphone app, providing women with a simple, non-invasive, drug-free way to strengthen their pelvic floor muscles to improve UI symptoms. raised only requires five minutes of practice a day, which women can do at home, on their own schedule. Multiple clinical trials and published data support to get up efficiency. raised is available by prescription only.

“As one of the largest private OB/GYN practices in the Mid-Atlantic region, we have a long history of clinical excellence,” said Craig Dickman, MD, FACOG, Vice Chair of the Board of Capital Women’s Care. “Female urinary incontinence is a widely undertreated condition that impacts a woman’s ability to participate in the activities she enjoys like traveling, socializing with friends, and exercising. We are pleased to offer a simple and effective home treatment for UI that is medication – and without surgery. raised enables our team of physicians to remain embedded in the success of our patients, which aligns well with our mission to nurture the spirit of caring for every woman. »

“Today, more than 78 million American women suffer from a treatable disease that impacts their social life, exercise preferences, relationships and travel plans – and that’s not true,” said Eileen Maus, CEO of Renovia. “We commend Capital Women’s Care for its commitment to providing women with the best care possible, which includes maintaining the strength of their pelvic floor. Digital medicine is the future of healthcare as it provides clinicians at CWC a convenient and effective way to stay in touch with their patients throughout their healing journey.We are delighted to work with a group of providers who share our deep commitment to ensuring that women can live leak-free.

About raised® Pelvic health system
the raised Pelvic Health System offers women a new, non-invasive, drug-free way to train and strengthen their pelvic floor muscles – at home in just five minutes a day – to treat urinary incontinence (UI). Combining a small FDA-approved vaginal wand connected to a smartphone app, raised offers accurate real-time visualization of pelvic movement, enables progress tracking, and enables active physician involvement, all of which support women’s success. Recognizing that level one evidence shows that pelvic floor muscle training is most effective when performed under the supervision of a qualified healthcare professional, raised is available by prescription only, allowing physicians to treat UI at scale and with continued commitment to patient success. raised is the first femtech product included in the Digital Therapeutics Alliance product library and has multiple clinical trials and published data from globally recognized medical centers supporting its effectiveness in treating UI. The Renovia clinical study works with raised received the 2021 Medical Device Network Excellence Award for Research and Development.

About Renovia
BostonRenovia Inc. is a women-led company dedicated to improving the lives of women with pelvic floor disorders. Renovia’s flagship product, the raised® Pelvic health system, offers a new, effective first-line treatment for urinary incontinence (UI), an underreported condition experienced by more than 78 million women in the United States alone. Renovia’s technology enables non-invasive, drug-free treatment through accurate visualization of real-time movement during pelvic floor muscle training, while monitoring usage and progress. For more information on Renovia or raised please visit and and follow us on TwitterFacebook, LinkedIn and Instagram.

Important instructions and other information for the raised Pelvic health system
the raised Pelvic Health System is intended for strengthening pelvic floor muscles and rehabilitating and training weak pelvic floor muscles for the treatment of mild to moderate stress, mixed and urge urinary incontinence (including overactive bladder) in women. Treatment with the raised The system is prescription and is not for everyone. Please speak to your prescribing physician to see if raised is good for you. Your prescriber should discuss all potential benefits and risks with you. Do not use raised during pregnancy or if you think you may be pregnant, unless approved by your doctor. For a full summary of the risks and instructions for raised system, consult its instructions for use available on and

Renovia Inc. and raised® are trademarks or registered trademarks of Renovia Inc. in United States and other countries. All rights reserved.

Media inquiries:
Shanti Skiffington
mobile: 617 921-0808


View original content: -dc-301496866.html

SOURCE Renovia Inc.

Source link


Comments are closed.